FOR IMMEDIATE RELEASE
Middleton, Wisconsin – April 22, 2005 – Bone Care International, Inc. (Nasdaq: BCII) today announced that management will present at the Deutsche Bank 30th Annual Health Care Conference at 2:00 pm EDT on Tuesday, May 3, 2005 at the Hyatt Regency Hotel in Baltimore, Maryland. The presentation will be webcast live and available for replay for 60 days. The direct link to the webcast is: http://www.corporate-ir.net/ireye/confLobby.zhtml?ticker=BCII&item_id=1026208
Bone Care International (www.bonecare.com) is a specialty pharmaceutical company engaged in the discovery, development and commercialization of innovative therapeutic products to treat the unmet medical needs of patients with debilitating conditions and life-threatening diseases. Our current commercial and therapeutic focus is in nephrology, utilizing Hectorol® (doxercalciferol), our novel vitamin D hormone therapy, to treat secondary hyperparathyroidism in patients with moderate to severe chronic kidney disease and end-stage renal disease. In addition to chronic kidney disease, the company is developing vitamin D hormone therapies to treat hyperproliferative disorders such as cancer and psoriasis.
Contact:
Bone Care International, Inc.
Brian J. Hayden, Chief Financial Officer
(608) 662-7800
